LONDON--(BUSINESS WIRE)--UK pharmaceutical research and development specialist MedPharm Ltd today announced that it is to move R&D operations from London to new R&D laboratories on the Surrey Research Park, Guildford, UK (30 miles S.W. of London). The move will be completed by mid- October and is in response to increased demand for both the company’s general pharmaceutical development services (formulation and analytical) and its innovative topical delivery technologies in particular MedSpray™ and MedNail. MedPharm’s (CRO) contract business has had another successful year of growth, with an increase in revenue of over 20%. This rise in business has been a key driver in the company’s relocation in order to ensure the continued expansion of MedPharm.
